11/18
10:20 am
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
11/18
10:07 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
11/18
07:17 am
rckt
Rocket Pharmaceuticals downgraded to Underweight from Neutral at JPMorgan
Low
Report
Rocket Pharmaceuticals downgraded to Underweight from Neutral at JPMorgan
11/7
11:30 pm
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
11/7
11:30 pm
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
10/14
02:20 pm
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
10/14
02:00 pm
rckt
Rating for RCKT
Low
Report
Rating for RCKT
10/3
11:13 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT